A detailed history of Monaco Asset Management Sam transactions in Novavax Inc stock. As of the latest transaction made, Monaco Asset Management Sam holds 85,000 shares of NVAX stock, worth $1.13 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares
85,000
Previous 188,900 55.0%
Holding current value
$1.13 Million
Previous $902,000 19.29%
% of portfolio
0.18%
Previous 0.28%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 07, 2024

SELL
$3.89 - $20.97 $404,171 - $2.18 Million
-103,900 Reduced 55.0%
85,000 $1.08 Million
Q1 2024

May 09, 2024

BUY
$3.76 - $6.02 $457,783 - $732,941
121,751 Added 181.31%
188,900 $902,000
Q4 2023

Feb 07, 2024

BUY
$4.8 - $7.67 $178,315 - $284,932
37,149 Added 123.83%
67,149 $322,000
Q3 2023

Nov 07, 2023

SELL
$6.81 - $9.74 $234,066 - $334,773
-34,371 Reduced 53.4%
30,000 $217,000
Q2 2023

Aug 08, 2023

BUY
$6.67 - $9.52 $429,354 - $612,811
64,371 New
64,371 $478,000

Others Institutions Holding NVAX

About NOVAVAX INC


  • Ticker NVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,215,104
  • Market Cap $1.04B
  • Description
  • Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...
More about NVAX
Track This Portfolio

Track Monaco Asset Management Sam Portfolio

Follow Monaco Asset Management Sam and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Monaco Asset Management Sam, based on Form 13F filings with the SEC.

News

Stay updated on Monaco Asset Management Sam with notifications on news.